ENCOD
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
February 27, 2008  |  By ENCOD In Uncategorized

DE: DIAMORPHINBEHANDLUNG WEITERHIN MÖGLICH

arton1129

Betreff: [GESUNDHEIT ADHOC] Vorwürfe der Grünen sind falsch

BMG – Die Drogenbeauftragte der Bundesregierung,

Montag, 25.02.2008 – 13:37 Uhr

Vorwürfe der Grünen sind falsch


Berlin – Die Drogenbeauftragte der Bundesregierung, Sabine Bätzing, stellt angesichts der aktuellen Vorwürfe klar:

“Die Diamorphinbehandlung kann in den bestehenden Ambulanzen in Bonn, Frankfurt, Hamburg, Hannover, Karlsruhe,
Köln und München unverändert fortgeführt werden. Für die Patienten ändert sich nichts. Kursierende Meldungen,
die das Ende der Diamorphinbehandlung an die Wand malen, sind irreführend. Ich trete unverändert dafür ein,
dass der Gesetzentwurf des Bundesrates möglichst bald durch den Bundestag verabschiedet wird.

Der von den Grünen erhobene Vorwurf des Wortbruchs von SPD und CDU ist deshalb schlicht falsch.”

Die rechtliche Grundlage für die Fortführung ist die Ausnahmeregelung nach §°3°Abs. 2°Betäubungsmittelgesetz.

Eine Genehmigung der Diamorphinbehandlung auf dieser Basis haben alle sieben Standorte erhalten.

Für Hamburg und München läuft die Frist bis Mitte 2008, für alle anderen Städte bis Mitte 2010. Frankfurt,
Karlsruhe und Köln können aufgrund ihres Antrags auch neue Patientinnen und Patienten in die Behandlung aufnehmen;
die anderen Standorte hatten auf diese Erweiterungsmöglichkeit im Antrag verzichtet.

Die Bundesregierung hat das Heroinmodellprojekt und die bisherige Fortführung der Diamorphinbehandlung
mit über 15 Millionen Euro gefördert. Eine weitere Bezuschussung der Behandlung aus Bundesmitteln ist nicht möglich,
da alle Forschungsfragen beantwortet sind. Gemessen an den gesamten Behandlungskosten ist der Anteil
der Bundesförderung für die laufende Behandlung vergleichsweise gering; für die finanzielle Absicherung
der Behandlung spielen diese Beträge keine entscheidende Rolle.
Sabine Bätzing: “Die Fortführung der Diamorphinbehandlung liegt mir unverändert am Herzen.

Deshalb unterstütze ich die geplante Förderung der Qualitätssicherung der weiteren Diamorphinbehandlung
durch das Zentrum für Interdisziplinäre Suchtforschung der Universität Hamburg
aus Mitteln des Bundesministeriums für Gesundheit.”

Kontakt: HAUSANSCHRIFT
Friedrichstraße 108, 10117 Berlin

POSTANSCHRIFT: 11055 Berlin

TEL + 49 (0)30 18441-1452, FAX + 49 (0)30 18441-4960

E-Mail: drogenbeauftragte@bmg.bund.de

Previous StoryLISTA DOS SOCIOS
Next StoryUK GOVERNMENT RESPONDS TO CSC PETITION

Related Articles

  • arton1484
    PILLENWARNUNGEN
  • arton1477
    AKZEPTANZ NEWSLETTER

Categories

Archives

  • About us
  • Downloads
  • Contact
  • Privacy Policy
  • Legal Notice & Terms of Use
  • Imprint

Copyright ©2018 ThemeFuse. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

REPUBLISHING TERMS

You may republish this article online or in print under our Creative Commons license. You may not edit or shorten the text, you must attribute the article to ENCOD and you must include the author’s name in your republication.

If you have any questions, please email thujer@gmail.com

License

Creative Commons License AttributionCreative Commons Attribution
DE: DIAMORPHINBEHANDLUNG WEITERHIN MÖGLICH